Manufacturers Life Insurance Company, The Athersys, Inc Transaction History

Manufacturers Life Insurance Company, The

  • $102 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.18 - $0.86 $17,757 - $84,842
-98,654 Closed
0 $0
Q1 2022

Aug 11, 2023
BUY
$0.6 - $1.06 $59,192 - $104,573
98,654 New
98,654 $60,000
Q1 2022

May 20, 2022
SELL
$0.6 - $1.06 $15,993 - $28,255
-26,656 Reduced 21.27%
98,654 $60,000
Q3 2021

Nov 12, 2021
SELL
$1.33 - $1.77 $7,305 - $9,722
-5,493 Reduced 4.2%
125,310 $167,000
Q2 2021

Aug 12, 2021
BUY
$1.41 - $1.94 $35,543 - $48,903
25,208 Added 23.87%
130,803 $188,000
Q1 2021

May 03, 2021
SELL
$1.61 - $2.77 $6,066 - $10,437
-3,768 Reduced 3.45%
105,595 $190,000
Q4 2020

Feb 12, 2021
BUY
$1.55 - $2.24 $12,818 - $18,524
8,270 Added 8.18%
109,363 $191,000
Q2 2020

Aug 10, 2020
BUY
$1.97 - $3.98 $22,903 - $46,271
11,626 Added 12.99%
101,093 $278,000
Q1 2020

May 15, 2020
BUY
$1.17 - $3.0 $3,893 - $9,984
3,328 Added 3.86%
89,467 $268,000
Q4 2019

Feb 14, 2020
SELL
$1.16 - $1.42 $3,695 - $4,524
-3,186 Reduced 3.57%
86,139 $106,000
Q2 2019

Aug 14, 2019
BUY
$1.39 - $2.03 $9,661 - $14,110
6,951 Added 8.44%
89,325 $150,000
Q1 2019

May 13, 2019
BUY
$1.39 - $1.71 $3,258 - $4,008
2,344 Added 2.93%
82,374 $124,000
Q4 2018

Feb 14, 2019
SELL
$1.41 - $2.16 $3,708 - $5,680
-2,630 Reduced 3.18%
80,030 $115,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $21,018 - $24,634
-11,300 Reduced 12.03%
82,660 $174,000
Q2 2018

Aug 14, 2018
BUY
$1.76 - $2.79 $20,303 - $32,185
11,536 Added 14.0%
93,960 $185,000
Q1 2018

May 15, 2018
SELL
$1.34 - $2.03 $95 - $144
-71 Reduced 0.09%
82,424 $151,000
Q4 2017

Feb 08, 2018
SELL
$1.65 - $2.45 $3,564 - $5,292
-2,160 Reduced 2.55%
82,495 $149,000
Q3 2017

Nov 14, 2017
BUY
$1.5 - $2.55 $126,982 - $215,870
84,655
84,655 $174,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email